The National Health Regulatory Authority today approved the emergency use of the Johnson & Johnson Covid-19 vaccine.
The vaccine is developed by Janssen Vaccines, which is part of Johnson & Johnson (J&J) in the Netherlands. It is the fifth vaccine to be authorized in Bahrain for emergency use for groups at high risk of infection.
The vaccine is taken as a single dose only and provides strong protection against severe infection with Covid-19.
